Investor insights
Sectors invested in
Antibody-based therapies1
Medical1
Biotechnology1
Radiation Induced Lung Injury1
NAMPT (nicotinamide phosphoribosyltransferase)1
Prostate Cancer1
eNamptorTM1
Acute Respiratory Distress Syndrome (ARDS)1
ventilator induced lung injury1
trauma-induced inflammatory lung injury1
inflammatory disorders1
humanized mAb1
Funding rounds participated in
$2.5M sweet spot round size
Most of their 1 investments are in rounds between $2.5M and $2.5M
Basic info
Industry
biotechnology research
Sectors
Manufacturing
Information Technology
Date founded
2012
Investments made
A
AQUALUNG THERAPEUTICS CORPORATION raised $2.5M on January 18, 2022
Investors: JSR Life Sciences